RecruitingNCT04844944
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
The Helios Heart Registry: A Standardized Registry for Capturing Clinical and Patient-reported Outcomes in Patients With Specific Cardiac Diseases: Application of the ICHOM Standard in Clinical Practice
Sponsor
Helios Health Institute GmbH
Enrollment
24,000 participants
Start Date
Mar 30, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Investigator-initiated, prospective, non-randomized, open label, non-interventional multicenter registry to evaluate current treatment of three major cardiovascular disease entities in clinical practice using a standardized variable-set of relevant covariates and outcome measures.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age of 18 years or older
- Inpatient Treatment
- Present diagnosis of at least one of the three cardiovascular disease entities of interest according to the current guidelines of the European Society of Cardiology (ESC): HF, CAD, AF
Exclusion Criteria3
- Inability to provide informed consent
- Initial presentation (index hospitalization) in cardiogenic shock or other kinds of shock
- Patient after heart transplantation or patient with present ventricular assist device (VAD)
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04844944
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations